Neovaginoplasty Using Photoinduced-imine-crosslink Hydrogel in MRKH Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorObstetrics & Gynecology Hospital of Fudan University
About this trial
Evaluating the effectiveness and safety of neovaginoplasty using photoinduced-imine-crosslink hydrogel in patients with MRKH syndrome by comparing the differences in the degree of squamous epithelialization, vaginal length and width, and sexual life quality.
Eligibility criteria
Qualifiers
Diagnosed with MRKH syndrome;
Without previous related treatments; 3)18-35 years old;
Disqualifiers
With any previous artificial colpoplasty or other related treatment;
With history of diabetes or systemic immune system disease.
Trial design
Treatments tested in this trial
- neovaginoplasty and vaginal mold spreaded with photoinduced-imine-crosslink hydrogel
- neovaginoplasty and vaginal mold
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov